MRSA: The cure
New drug undergoing human trials offers hope of breakthrough. Gel placed in the nose could beat superbug that kills 1,600 every year
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.A cure for MRSA appears to be within grasp after scientists claimed to have developed a drug that destroys the most virulent strains of the deadly superbug. The breakthrough by British researchers could save 1,600 lives a year and wipe out the highly infectious bacteria.
A landmark peer-reviewed study has found that in the lab MRSA does not develop resistance to the drug, as it does to antibiotics. Tests showed that the XF-73 "bacteriocidal" compound continued to destroy MRSA after repeated treatment, long past the stage when it would have become resistant to antibiotics.
MRSA has proved to be an intractable problem in hospitals, despite repeated government initiatives – concentrating on improved staff hygiene and deep-cleaning programmes – to eradicate it.
Doctors and patients would be able to apply the drug, carried in a gel, in the nostril to protect them from infection.
Scientists at Sussex-based Destiny Pharma are now carrying out human trials and could have a product ready within three years.
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments